Phase 3 Patent Ductus Arteriosus Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT

Patent Ductus Arteriosus After Premature Birth

IWK Health Centre100 enrolled9 locationsNCT05011149

Recruiting

Phase 3

Treatment of Patent Ductus Arteriosus with Paracetamol

Patent ductus arteriosus in very low birth weight neonates

Sapienza University of Rome90 enrolled1 locationACTRN12613000289718